Emerging retatrutide, a combined-action drug targeting both GLP-1 and GIP receptors, is sparking considerable buzz within the weight loss community. Initial clinical research have demonstrated substantial losses in overall mass and improvements in health markers for people with excess weight . Researchers believe this ground-breaking approach ha… Read More